Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,949 | 198 | 99.5% |
| Education | $14.37 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $655.47 | 47 | $0 (2024) |
| ABBVIE INC. | $332.66 | 22 | $0 (2024) |
| Abbott Laboratories | $286.46 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $244.95 | 18 | $0 (2020) |
| Lilly USA, LLC | $213.38 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203.89 | 15 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $156.09 | 11 | $0 (2020) |
| GlaxoSmithKline, LLC. | $143.90 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $135.94 | 8 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $76.92 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.66 | 23 | Abbott Laboratories ($144.64) |
| 2023 | $308.65 | 18 | Abbott Laboratories ($62.98) |
| 2022 | $352.34 | 23 | Novo Nordisk Inc ($102.14) |
| 2021 | $283.13 | 19 | AbbVie Inc. ($154.92) |
| 2020 | $167.47 | 12 | Novo Nordisk Inc ($57.60) |
| 2019 | $478.53 | 38 | Lilly USA, LLC ($127.34) |
| 2018 | $494.89 | 39 | Novo Nordisk Inc ($156.07) |
| 2017 | $444.73 | 28 | Janssen Pharmaceuticals, Inc ($135.94) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Biological | ||||||
| 10/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes Care | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Biological | ||||||
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: PAIN | ||||||
| 07/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Biological | ||||||
| 07/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes Care | ||||||
| 06/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.35 | General |
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Diabetes Care | ||||||
| 03/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes Care | ||||||
| 03/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 02/15/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 01/09/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes Care | ||||||
| 11/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.37 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 565 | 805 | $188,415 | $75,296 |
| 2022 | 15 | 494 | 774 | $167,239 | $64,922 |
| 2021 | 13 | 512 | 694 | $150,483 | $59,503 |
| 2020 | 16 | 606 | 792 | $146,703 | $56,303 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 375 | $105,375 | $36,896 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 139 | 139 | $39,893 | $19,556 | 49.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $9,522 | $5,048 | 53.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 42 | $6,146 | $3,008 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 41 | $8,159 | $3,005 | 36.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 16 | $7,280 | $2,852 | 39.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 57 | $3,814 | $1,874 | 49.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $2,106 | $822.78 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,952 | $820.37 | 27.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,507 | $788.88 | 52.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 14 | 15 | $673.00 | $327.69 | 48.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 20 | $820.00 | $203.04 | 24.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 28 | $168.00 | $95.48 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 323 | $91,144 | $31,760 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 87 | 87 | $24,045 | $12,547 | 52.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $8,578 | $3,442 | 40.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 19 | 65 | $7,177 | $2,715 | 37.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 15 | 51 | $6,851 | $2,452 | 35.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 34 | $6,792 | $2,236 | 32.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 33 | 33 | $4,620 | $2,193 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 33 | $6,582 | $2,136 | 32.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $3,276 | $1,843 | 56.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $2,640 | $1,300 | 49.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 11 | 23 | $2,037 | $754.68 | 37.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 13 | $1,521 | $610.41 | 40.1% |
About Dr. Durr-E-Shahwaar Sayed, DO
Dr. Durr-E-Shahwaar Sayed, DO is a Family Medicine healthcare provider based in Glassboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1821228263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Durr-E-Shahwaar Sayed, DO has received a total of $2,963 in payments from pharmaceutical and medical device companies, with $433.66 received in 2024. These payments were reported across 200 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,949).
As a Medicare-enrolled provider, Sayed has provided services to 2,177 Medicare beneficiaries, totaling 3,065 services with total Medicare billing of $256,024. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Glassboro, NJ
- Active Since 07/20/2009
- Last Updated 11/20/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821228263
Products in Payments
- FARXIGA (Drug) $219.13
- FREESTYLE LIBRE 3 (Device) $207.62
- Ozempic (Drug) $193.52
- UBRELVY (Drug) $168.56
- TRULICITY (Drug) $162.54
- Saxenda (Drug) $149.92
- TRADJENTA (Drug) $124.43
- Victoza (Drug) $123.97
- JANUVIA (Drug) $115.44
- INVOKANA (Drug) $97.45
- VRAYLAR (Drug) $92.49
- QULIPTA (Drug) $86.08
- JARDIANCE (Drug) $79.46
- ENTRESTO (Drug) $61.67
- BEXSERO (Biological) $55.52
- Veozah (Drug) $46.86
- TRELEGY ELLIPTA (Drug) $44.14
- Rybelsus (Drug) $43.49
- INTELLIS ADAPTIVESTIM (Device) $39.41
- XARELTO (Drug) $38.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Glassboro
Dr. Bac Nguyen, Md, MD
Family Medicine — Payments: $18,248
Jon Heist, Do, DO
Family Medicine — Payments: $7,427
Dr. Steven Meskin, Md, MD
Family Medicine — Payments: $5,191
Ms. Mavola Tench, Md, MD
Family Medicine — Payments: $4,622
Dr. Joseph Szgalsky, Md, Faafp, MD, FAAFP
Family Medicine — Payments: $4,197
Anna Alberici, D.o, D.O
Family Medicine — Payments: $1,514